Anzeige
Mehr »
Login
Samstag, 13.08.2022 Börsentäglich über 12.000 News von 669 internationalen Medien
Innocan Pharma: 15 Mal besser als der Status Quo!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2H63F ISIN: US84833T1034 Ticker-Symbol: 2HA 
Frankfurt
12.08.22
09:16 Uhr
0,741 Euro
-0,067
-8,29 %
1-Jahres-Chart
SPERO THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SPERO THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,7670,78312.08.
0,7460,79712.08.

Aktuelle News zur SPERO THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSpero Therapeutics, Inc.: Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business Update-
MiSpero Therapeutics, Inc. - 8-K, Current Report1
MiSpero Therapeutics, Inc. - 10-Q, Quarterly Report1
SPERO THERAPEUTICS Aktie jetzt für 0€ handeln
DiSpero Therapeutics, Inc.: Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022-
01.07.Spero Therapeutics, Inc. - 8-K, Current Report2
28.06.Spero's UTI candidate gets the CRL hammer as the company falls into penny stock status1
28.06.The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives2
27.06.Spero Therapeutics' Shares Plunge As FDA Issued Refusal Letter For Urinary Tract Infection Candidate4
27.06.US FDA declines to approve Spero's urinary tract infection drug1
27.06.FDA rejects Spero's application seeking approval of its urinary tract infection tablets1
27.06.Spero Therapeutics, Inc.: Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug Application-
07.06.Spero Therapeutics, Inc. - 8-K, Current Report1
17.05.Where Spero Therapeutics Stands With Analysts1
17.05.Recap: Spero Therapeutics Q1 Earnings1
11.05.Spero Therapeutics, Inc.: Spero Therapeutics to Present at Upcoming Investor Conferences-
09.05.Spero Therapeutics, Inc.: Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 20223
04.05.Spero downgraded at Cowen after regulatory setback to lead asset5
03.05.Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge1
03.05.SPRO Stock Alert: 9 Things to Know as Spero Therapeutics Plunges 50%5
03.05.Bad news from FDA prompts Spero to lay off 75% of staff, drop UTI drug5
Seite:  Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1